Tenaya Therapeutics, Inc.
TNYA • NASDAQ
Tenaya Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Faraz Ali, with a market cap of $160.6M.
Market Cap$160.6M
Employees140.0
CEOFaraz Ali
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Tenaya Therapeutics, Inc. FAQ
Common questions about Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $8.5M.
Tenaya Therapeutics, Inc. has approximately 140 employees.